Do you want to read an article? Please log in or register.
Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Consensus Statement on Managing Anxiety and Depression in Individuals with Inflammatory Bowel Disease
Inflamm Bowel Dis
Hinnant L, Rios Villacorta N, Chen E, Bacchus D, Dotson J, Greywoode R, Keefer L, Lupe S, Maggs L, Meek G, Szigethy E, Tomasino K, Ehrlich OG, Ehle S
doi: 10.1093/ibd/izae151
Inflammatory Bowel Disease
Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab
Inflamm Bowel Dis
Porth R, Deyhim T, Zullow S, Rabinowitz LG, Grossberg LB, Roblin X, Paul S, Cheifetz AS, Papamichael K
doi: 10.1093/ibd/izae140
Inflammatory Bowel Disease
Sex and gender in inflammatory bowel disease outcomes and research
Lancet Gastroenterol Hepatol
Andersen V, Pingel J, Søfelt HL, Hikmat Z, Johansson M, Pedersen VS, Bertelsen B, Carlsson A, Lindh M, Svavarsdóttir E, Repsilber D, Joergensen MT, Christensen R, Fejrskov A, Füchtbauer JD, Kjeldsen J, Jensen MD, Aalykke C, Rejler M, Høivik ML, Davidsdottir L, Carlson M, Halfvarson J, Zachariassen HH, Petersen LB, Myers ES
doi: 10.1016/S2468-1253(24)00159-6
Inflammatory Bowel Disease
Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study
Inflamm Bowel Dis
Petrov JC, Desai AA, Kochhar GS, Crosby SK, Kinnucan JA, Picco MF, Hashash JG, Farraye FA
doi: 10.1093/ibd/izae147
Inflammatory Bowel Disease
Prevalence and Risk Factors of Spondyloarthritis Symptoms in a US-Based Multicenter Cohort of Patients with Inflammatory Bowel Disease
Am J Gastroenterol
Hong SJ, Dalal RS, Kuhn KA, Stahly A, Scott F, Click B, Way A, Malik F, Davis JM 3rd, Shmais M, Raffals L, Silfen A, Rubin DT, Dharia I, Bhattacharya A, Moghaddam B, Mains T, Kurland J, Patel S, Weisman MH, Ermann J, Jan R
doi: 10.14309/ajg.0000000000003292
RECOMMENDED
Inflammatory Bowel Disease
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology
Hanžel J, Solitano V, Vuyyuru SK, Panaccione R, Sands BE, Peyrin-Biroulet L, Danese S, D'Haens GR, Atreya R, Allez M, Bernstein CN, Bossuyt P, Bressler B, Bryant RV, Cohen BL, Colombel JF, D'Amico F, Dignass A, Dubinsky M, Fleshner P, Gearry RB, Hanauer SB, Hart AL, Kayal M, Kucharzik T, Lakatos PL, Louis E, Magro F, Narula N, Leong RW, Panés J, Raine T, Ran Z, Regueiro MD, Reinisch W, Singh S, Steinhart AH, Travis S, Ungaro RC, Janneke van der Woude C, Yamamoto T, Ahuja V, Rubin DT, Dulai PS, Cornfield LJ, Hogan M, Sandborn WJ, Feagan BG, Jairath V, Ma C
doi: 10.1053/j.gastro.2025.05.015
Inflammatory Bowel Disease
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study
Lancet Gastroenterol Hepatol
Atia O, Shavit-Brunschwig Z, Lev-Tzion R, Stein R, Broide E, Urlep D, Hyams J, Weiss B, Aloi M, Assa A, Gerasimidis K, Nichols B, Russell RK, Turner D
doi: 10.1016/S2468-1253(24)00319-4
Inflammatory Bowel Disease
Clinical outcomes after first-line anti-TNF treatment of patients with inflammatory bowel disease - a prospective multicenter cohort study
J Crohns Colitis
Zhao M, Larsen L, Dige A, Poulsen A, Lo B, Attauabi M, Dige Ovesen P, Wewer MD, Christiansen D, Hvas CL, Petersen AM, Bendtsen F, Seidelin J, Burisch J
doi: 10.1093/ecco-jcc/jjae192
Inflammatory Bowel Disease
Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-Based Cohort Study 1997-2020
Clin Gastroenterol Hepatol
Jacobsen HA, Karachalia-Sandri A, Ebert AC, Allin KH, Ananthakrishnan AN, Agrawal M, Ungaro RC, Colombel JF, Larsen L, Jess T
doi: 10.1016/j.cgh.2024.10.021